LivingGLP1
Condition P15

Antipsychotic associated weight gain and severe mental illness

People with schizophrenia or other severe mental illness with weight gain on antipsychotics.

4 randomized trials; 0 fitted analyses across 1 outcomes.

All outcomes

Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.

Percent body weight change (short trials)primary

O10B
Time windowEstimandTreatmentsTrialsNodesAnalysis
weeks 12 to 52 (target week 24)Not stated by the trialsEach dose separately12Descriptive only
weeks 12 to 52 (target week 24)Not stated by the trialsDoses of a drug pooled12Descriptive only